A carregar...

Moving treatments earlier to move further forward

In 2017, results from phase III trials demonstrated the impressive safety and efficacy of adjuvant targeted and immune therapies in patients with resectable stage III–IV melanoma, and raised questions about the surgical management of patients with microscopic sentinel-lymph-node metastases. For pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Rev Clin Oncol
Main Authors: Davies, Michael A., Flaherty, Keith T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436336/
https://ncbi.nlm.nih.gov/pubmed/29182162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2017.183
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!